| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7fd15d8ebb22202b5cfe2b109cd922c5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-868
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-862
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-11 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2006-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0586ce70ccff0d7c71ffb6241ed44d7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ce3b80e55544833d2759cc71404b84e |
| publicationDate |
2006-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006165677-A1 |
| titleOfInvention |
DELETION FORMS OF IgE-DEPENDENT HISTAMINE RELEASING FACTOR HAVING HISTAMINE RELEASING ACTIVITY, HRF-BINDING PEPTIDES AND THE USES THEREOF |
| abstract |
The present invention relates to IgE-dependent histamine releasing factor (HRF) and HRF-binding peptides, more precisely, deletion forms of HRF which are able to be formed as dimers containing amino acid sequence represented by SEQ ID NO:3, genes encoding thereof and novel HRF-binding peptides having an activity of inhibiting HRF. The deletion forms of HRF which are able to be formed as dimers of the present invention induces intracellular secretion of histamine and IL-8, making an excellent candidate for a drug for inhibiting allergic reaction triggered by HRF and a kit for detecting HRF in serum of an allergy patient. In addition, novel HFR-binding peptides of the present invention bind to HRF to inhibit the actions of HFR, so they can be effectively used for the prevention and the treatment of allergic diseases of animals including asthma and rhinitis or malaria. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11518805-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015037330-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019056412-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020102108-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10703812-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013136742-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015194831-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10370438-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101843051-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101804285-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9907857-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016204541-A1 |
| priorityDate |
2005-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |